IC14 for Treatment of Amyotrophic Lateral Sclerosis

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

August 15, 2021

Primary Completion Date

May 15, 2023

Study Completion Date

December 15, 2023

Conditions

Amyotrophic Lateral SclerosisMotor Neuron Disease

Interventions

BIOLOGICAL

IC14

Monoclonal antibody against CD14

OTHER

Placebo

sterile normal saline for injection prepared to be identical to study drug

Trial Locations (1)

Royal Brisbane and Women's Hospital, Herston